| At a glance | 2000 | 2011 | 2021 | 2030 | 2045 |
|---|---|---|---|---|---|
| Diabetes estimates (20-79 y) | |||||
| People with diabetes, in 1,000s | 123.9 | 527.9 | 396.1 | 469.0 | 593.6 |
| Age-adjusted comparative prevalence of diabetes, % | - | 19.6 | 8.0 | 9.2 | 10.0 |
| People with undiagnosed diabetes, in 1,000s | - | - | 159.4 | - | - |
| Proportion of people with undiagnosed diabetes, % | - | - | 40.2 | - | - |
| Impaired glucose tolerance (IGT) estimates (20-79 y) | |||||
| People with IGT, in 1,000s | - | 206.2 | 327.2 | 333.9 | 365.7 |
| Age-adjusted comparative prevalence of IGT, % | - | 7.5 | 10.0 | 10.3 | 10.4 |
| Impaired fasting glucose (IFG) estimates (20-79 y) | |||||
| People with IFG, in 1,000s | - | - | 523.7 | 542.4 | 611.8 |
| Age-adjusted comparative prevalence of IFG, % | - | - | 9.8 | 10.1 | 10.4 |
| Mortality attributable to diabetes (20-79 y) | |||||
| Deaths attributable to diabetes | - | 4,525.0 | 5,491.9 | - | - |
| Proportion of diabetes-related deaths in people under 60 y, % | - | - | 2.9 | - | - |
| Type 1 diabetes estimates in children and adolescents | |||||
| New cases of type 1 diabetes (0-14 y), in 1,000s | 0.1 | - | 0.1 | - | - |
| New cases of type 1 diabetes (0-19 y), in 1,000s | - | - | 0.1 | - | - |
| Type 1 diabetes (0-14 y), in 1,000s | 0.3 | - | 0.3 | - | - |
| Type 1 diabetes (0-19 y), in 1,000s | - | - | 0.6 | - | - |
| Hyperglycaemia in pregnancy (HIP) (20-49 y) | |||||
| Live births affected by HIP | - | - | - | - | - |
| Prevalence of gestational diabetes mellitus (GDM), % | - | - | - | - | - |
| Live births affected by other types of diabetes first detected in pregnancy | - | - | - | - | - |
| Live births affected by other types of diabetes detected prior to pregnancy | - | - | - | - | - |
| Diabetes-related health expenditure | |||||
| Total diabetes-related health expenditure, USD million | - | - | 764.7 | 807.3 | 921.5 |
| Total diabetes-related health expenditure, ID million | - | - | 1,209.7 | 1,276.9 | 1,457.7 |
| Diabetes-related health expenditure per person, USD | - | 767.0 | 1,930.8 | 2,038.2 | 2,326.6 |
| Diabetes-related health expenditure per person, ID | - | - | 3,054.1 | 3,224.0 | 3,680.2 |
| Demographics | |||||
| Total adult population (20-79 y), in 1,000s | 1,875.0 | 2,788.6 | 4,449.4 | 4,333.9 | 4,649.2 |
| Population of children (0-14 y), in 1,000s | 1,131.0 | - | 1,656.1 | - | - |
| Population of children and adolescents (0-19 y), in 1,000s | - | - | 2,211.8 | - | - |
| Complications of diabetes | |||||
| Microvascular |
| ||||
| Macrovascular |
| ||||